National Asset Management Inc. lowered its stake in shares of CME Group Inc. (NASDAQ:CME) by 3.7% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,850 shares of the financial services provider’s stock after selling 224 shares during the period. National Asset Management Inc.’s holdings in CME Group were worth $734,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently added to or reduced their stakes in the company. Guardian Life Insurance Co. of America grew its stake in CME Group by 0.7% during the 1st quarter. Guardian Life Insurance Co. of America now owns 1,309 shares of the financial services provider’s stock valued at $156,000 after acquiring an additional 9 shares in the last quarter. Honkamp Krueger Financial Services Inc. grew its stake in CME Group by 0.4% during the 2nd quarter. Honkamp Krueger Financial Services Inc. now owns 2,937 shares of the financial services provider’s stock valued at $368,000 after acquiring an additional 13 shares in the last quarter. Hudock Capital Group LLC grew its stake in CME Group by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 3,890 shares of the financial services provider’s stock valued at $487,000 after acquiring an additional 20 shares in the last quarter. Whittier Trust Co. grew its stake in CME Group by 2.6% during the 2nd quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock valued at $133,000 after acquiring an additional 27 shares in the last quarter. Finally, Ropes Wealth Advisors LLC grew its stake in CME Group by 0.4% during the 2nd quarter. Ropes Wealth Advisors LLC now owns 10,801 shares of the financial services provider’s stock valued at $1,353,000 after acquiring an additional 38 shares in the last quarter. 82.64% of the stock is owned by institutional investors and hedge funds.
CME Group Inc. (CME) traded up 0.01% during trading on Friday, reaching $137.73. 385,488 shares of the company’s stock traded hands. CME Group Inc. has a 1-year low of $98.95 and a 1-year high of $138.49. The firm has a 50 day moving average of $131.99 and a 200 day moving average of $123.73. The firm has a market capitalization of $46.82 billion, a PE ratio of 28.11 and a beta of 0.73.
CME Group (NASDAQ:CME) last released its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.20 by $0.03. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The business had revenue of $925.00 million for the quarter, compared to analysts’ expectations of $931.05 million. During the same period last year, the company earned $1.14 earnings per share. The company’s quarterly revenue was up 2.1% on a year-over-year basis. Equities analysts forecast that CME Group Inc. will post $4.81 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Monday, September 25th. Investors of record on Friday, September 8th were given a $0.66 dividend. The ex-dividend date was Thursday, September 7th. This represents a $2.64 annualized dividend and a dividend yield of 1.92%. CME Group’s dividend payout ratio is presently 53.99%.
In related news, CFO John W. Pietrowicz sold 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, October 11th. The shares were sold at an average price of $136.83, for a total value of $342,075.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, President Bryan T. Durkin sold 9,200 shares of the firm’s stock in a transaction that occurred on Tuesday, August 8th. The stock was sold at an average price of $125.13, for a total transaction of $1,151,196.00. Following the completion of the sale, the president now directly owns 70,938 shares in the company, valued at $8,876,471.94. The disclosure for this sale can be found here. Insiders sold 49,594 shares of company stock worth $6,239,015 over the last three months. Corporate insiders own 0.57% of the company’s stock.
CME has been the subject of several research reports. BidaskClub raised shares of CME Group from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, September 27th. Barclays PLC upped their price objective on shares of CME Group from $139.00 to $149.00 and gave the company an “overweight” rating in a research note on Tuesday. Jefferies Group LLC reaffirmed a “buy” rating and set a $128.00 price objective on shares of CME Group in a research note on Monday, July 10th. UBS AG reaffirmed a “buy” rating and set a $135.00 price objective (up previously from $134.00) on shares of CME Group in a research note on Wednesday, September 6th. Finally, Keefe, Bruyette & Woods reaffirmed a “hold” rating and set a $127.00 price objective on shares of CME Group in a research note on Friday, July 14th. One analyst has rated the stock with a sell rating, three have given a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. CME Group has an average rating of “Buy” and an average target price of $135.89.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.